262 related articles for article (PubMed ID: 28795412)
1. Severe neurological disorders and refractory aspergillosis in an adolescent treated by vincristine and voriconazole.
Bennis Y; Bodeau S; Lutun A; Gourmel A; Solas C; Quaranta S; Guillaume N; Chouaki T; Lemaire-Hurtel AS; Masmoudi K
J Clin Pharm Ther; 2018 Apr; 43(2):265-268. PubMed ID: 28795412
[TBL] [Abstract][Full Text] [Related]
2. Clinical Analysis of Adverse Drug Reactions between Vincristine and Triazoles in Children with Acute Lymphoblastic Leukemia.
Yang L; Yu L; Chen X; Hu Y; Wang B
Med Sci Monit; 2015 Jun; 21():1656-61. PubMed ID: 26050202
[TBL] [Abstract][Full Text] [Related]
3. Voriconazole-associated visual disturbances and hallucinations.
Bayhan GI; Garipardic M; Karaman K; Akbayram S
Cutan Ocul Toxicol; 2016 Mar; 35(1):80-2. PubMed ID: 25799212
[TBL] [Abstract][Full Text] [Related]
4. Posaconazole-increased vincristine neurotoxicity in a child: a case report.
Eiden C; Palenzuela G; Hillaire-Buys D; Margueritte G; Cociglio M; Hansel-Esteller S; Peyriere H
J Pediatr Hematol Oncol; 2009 Apr; 31(4):292-5. PubMed ID: 19346885
[TBL] [Abstract][Full Text] [Related]
5. Adverse interactions between antifungal azoles and vincristine: review and analysis of cases.
Moriyama B; Henning SA; Leung J; Falade-Nwulia O; Jarosinski P; Penzak SR; Walsh TJ
Mycoses; 2012 Jul; 55(4):290-7. PubMed ID: 22126626
[TBL] [Abstract][Full Text] [Related]
6. Voriconazole-induced hepatotoxicity following the administration of PEG-asparaginase: Case report.
Gallant R; Bonney P; Peek L; Yu Z; Crawford D
Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27748018
[No Abstract] [Full Text] [Related]
7. Brain Abscesses Due to Aspergillus nidulans Infection During Induction Chemotherapy for Acute Lymphoblastic Leukemia.
Sadarangani M; Harvey M; McDonald A; Speert DP; Dix D
J Pediatr Hematol Oncol; 2015 Aug; 37(6):e384-6. PubMed ID: 25985238
[TBL] [Abstract][Full Text] [Related]
8. Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience.
Cesaro S; Strugo L; Alaggio R; Cecchetto G; Rigobello L; Pillon M; Cusinato R; Zanesco L
Support Care Cancer; 2003 Nov; 11(11):722-7. PubMed ID: 13680324
[TBL] [Abstract][Full Text] [Related]
9. Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients.
Harnicar S; Adel N; Jurcic J
J Oncol Pharm Pract; 2009 Sep; 15(3):175-82. PubMed ID: 19282418
[TBL] [Abstract][Full Text] [Related]
10. Disseminated invasive aspergillosis in a patient with acute leukaemia.
Gottfredsson M; Steingrímsdóttir H
Acta Biomed; 2006; 77 Suppl 2():10-3. PubMed ID: 16918060
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β-cyclodextrin in haematological patients with renal impairment.
Kim SH; Kwon JC; Park C; Han S; Yim DS; Choi JK; Cho SY; Lee HJ; Park SH; Choi SM; Choi JH; Yoo JH; Lee DG; Lee JW
Mycoses; 2016 Oct; 59(10):644-51. PubMed ID: 27324913
[TBL] [Abstract][Full Text] [Related]
12. Safety, Efficacy, and Exposure-Response of Voriconazole in Pediatric Patients With Invasive Aspergillosis, Invasive Candidiasis or Esophageal Candidiasis.
Martin JM; Macias-Parra M; Mudry P; Conte U; Yan JL; Liu P; Capparella MR; Aram JA
Pediatr Infect Dis J; 2017 Jan; 36(1):e1-e13. PubMed ID: 27636722
[TBL] [Abstract][Full Text] [Related]
13. Is It Time for Systematic Voriconazole Pharmacogenomic Investigation for Central Nervous System Aspergillosis?
Danion F; Jullien V; Rouzaud C; Abdel Fattah M; Lapusan S; Guéry R; Bigé N; Morgand M; Pallet N; Lanternier F; Lortholary O
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29967027
[TBL] [Abstract][Full Text] [Related]
14. Aggravation of vincristine-induced neurotoxicity by itraconazole in the treatment of adult ALL.
Böhme A; Ganser A; Hoelzer D
Ann Hematol; 1995 Dec; 71(6):311-2. PubMed ID: 8534764
[TBL] [Abstract][Full Text] [Related]
15. Fulminant peripheral neuropathy with severe quadriparesis associated with vincristine therapy.
Moudgil SS; Riggs JE
Ann Pharmacother; 2000 Oct; 34(10):1136-8. PubMed ID: 11054980
[TBL] [Abstract][Full Text] [Related]
16. Successful antifungal combination therapy with voriconazole and caspofungin.
Schuster F; Moelter C; Schmid I; Graubner UB; Kammer B; Belohradsky BH; Führer M
Pediatr Blood Cancer; 2005 Jun; 44(7):682-5. PubMed ID: 15700260
[TBL] [Abstract][Full Text] [Related]
17. Disseminated aspergillosis in an adolescent with acute lymphoblastic leukemia.
Zwitserloot AM; Warris A; van't Hek LG; van Die LE; Verweij PE; Mavinkurve-Groothuis AM
Pediatr Blood Cancer; 2008 Sep; 51(3):423-6. PubMed ID: 18478572
[TBL] [Abstract][Full Text] [Related]
18. Bilateral vocal cord paralysis following treatment with vincristine.
Naithani R; Dolai TK; Kumar R
Indian Pediatr; 2009 Jan; 46(1):68-9. PubMed ID: 19179723
[TBL] [Abstract][Full Text] [Related]
19. Azole-based chemoprophylaxis of invasive fungal infections in paediatric patients with acute leukaemia: an internal audit.
Yunus S; Pieper S; Kolve H; Goletz G; Jürgens H; Groll AH
J Antimicrob Chemother; 2014 Mar; 69(3):815-20. PubMed ID: 24198097
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of vincristine toxicity by itraconazole in children with lymphoid malignancies.
Kamaluddin M; McNally P; Breatnach F; O'Marcaigh A; Webb D; O'Dell E; Scanlon P; Butler K; O'Meara A
Acta Paediatr; 2001 Oct; 90(10):1204-7. PubMed ID: 11697438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
